Crossmark

The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial)

Crossref DOI link: https://doi.org/10.1007/s00520-022-06975-x

Published Online: 2022-03-21

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Joy, Lodewijckx

Jolien, Robijns

Marithé, Claes

Stijn, Evens

Laura, Swinnen

Hilde, Lenders

Sandra, Bortels

Wendy, Nassen

Ruth, Hilkens

Liesbeth, Raymakers

Sylvana, Snoekx

Sylvia, Hermans

Jeroen, Mebis
Funding

Funding for this research was provided by:

Limburg Clinical Research Center

Kom op tegen Kanker

Limburgs Kankerfonds

Limburgse Kankersamenwerking
License Information

Text and Data Mining valid from 2022-03-21

Version of Record valid from 2022-03-21
More Information

Article History

Received: 30 November 2021

Accepted: 10 March 2022

First Online: 21 March 2022

Declarations

:

: This research is approved by the ethics committees of the Jessa Hospital and the University of Hasselt (B243201733877). Informed consent was obtained from all individual participants included in the study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below